Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Directorate Change

19 Aug 2020 12:25

RNS Number : 6094W
Aberdeen Latin American Inc Fd Ltd
19 August 2020
 

ABERDEEN LATIN AMERICAN INCOME FUND LIMITED

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

 

Appointment of Non-Executive Director

 

19 August 2020

 

The Board of Aberdeen Latin American Income Fund Limited (the "Company") is pleased to announce the appointment of Howard Myles as an independent non-executive Director of the Company with effect from 1 October 2020. Mr Myles was appointed after a search conducted by an independent recruitment consultancy.

 

Richard Prosser, Chairman of the Company, said: "The Directors are delighted to welcome Howard to the Board. Howard brings a wealth of knowledge in relation to closed-end funds including experience of the Latin American region.

 

He was a partner with Ernst & Young from 2001 to 2007 and was responsible for the Investment Funds Corporate Advisory team having previously been with UBS Warburg. Starting his career as an equity salesman, he then joined Touche Ross & Co in 1975 where he qualified as a chartered accountant. In 1978 he joined W Greenwell & Co. in the corporate broking team and in 1987 moved to SG Warburg Securities where he was involved in a wide range of commercial and industrial transactions in addition to leading Warburg's corporate finance function for investment funds.

 

Howard is currently Senior Independent Director of BBGI SICAV and Audit Committee Chair of Chelverton UK Dividend Trust plc. He is Chairman of JP Morgan Brazil Investment Trust plc, from which he is due to retire on 17 September 2020, and Chairman of Baker Steel Resources Trust Limited."

 

Mr Myles will stand for election as a Director at the Annual General Meeting to be held on or around 10 December 2020.

 

In accordance with paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules, Mr Myles advises that, within the last five years, he stepped down as a non-executive Director of Lazard World Trust Fund in 2019 and Aberdeen Private Equity Fund Limited in 2018.

 

There are no other disclosures required to be made for Mr Myles in respect of paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules.

 

Mr Myles does not hold any interests in any of the Company's shares.

 

 

Aberdeen Standard Capital International Limited

Company Secretary

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAKKCBBDBKDNFD
Date   Source Headline
4th Feb 20213:01 pmRNSMonth End Net Asset Value(s)
4th Feb 202111:53 amRNSNet Asset Value(s)
4th Feb 20219:14 amRNSHolding(s) in Company
3rd Feb 202111:04 amRNSNet Asset Value(s)
2nd Feb 20211:34 pmRNSNet Asset Value(s)
1st Feb 20212:41 pmRNSGearing disclosure
29th Jan 202112:32 pmRNSNet Asset Value(s)
28th Jan 202111:40 amRNSNet Asset Value(s)
27th Jan 202111:44 amRNSNet Asset Value(s)
26th Jan 20211:01 pmRNSNet Asset Value(s)
25th Jan 20212:33 pmRNSGearing disclosure
25th Jan 202112:33 pmRNSNet Asset Value(s)
22nd Jan 202111:42 amRNSNet Asset Value(s)
21st Jan 202111:39 amRNSNet Asset Value(s)
20th Jan 202111:00 amRNSNet Asset Value(s)
19th Jan 202110:51 amRNSNet Asset Value(s)
18th Jan 202112:57 pmRNSGearing disclosure
18th Jan 202112:39 pmRNSNet Asset Value(s)
15th Jan 202111:47 amRNSNet Asset Value(s)
14th Jan 202111:41 amRNSNet Asset Value(s)
14th Jan 202110:45 amRNSPortfolio disclosure
13th Jan 202111:48 amRNSNet Asset Value(s)
12th Jan 202111:09 amRNSNet Asset Value(s)
11th Jan 202111:50 amRNSGearing disclosure
11th Jan 202111:14 amRNSNet Asset Value(s)
8th Jan 202111:06 amRNSNet Asset Value(s)
7th Jan 20213:12 pmRNSMonth End Net Asset Value(s)
7th Jan 202111:27 amRNSNet Asset Value(s)
6th Jan 202112:20 pmRNSNet Asset Value(s)
5th Jan 202111:29 amRNSNet Asset Value(s)
4th Jan 20212:45 pmRNSGearing disclosure
31st Dec 202012:36 pmRNSNet Asset Value(s)
30th Dec 202011:05 amRNSNet Asset Value(s)
29th Dec 20202:31 pmRNSGearing Disclosure
29th Dec 202012:09 pmRNSNet Asset Value(s)
24th Dec 202011:31 amRNSNet Asset Value(s)
23rd Dec 202011:47 amRNSNet Asset Value(s)
22nd Dec 202011:34 amRNSNet Asset Value(s)
21st Dec 20204:40 pmRNSSecond Price Monitoring Extn
21st Dec 20204:35 pmRNSPrice Monitoring Extension
21st Dec 20202:35 pmRNSGearing disclosure
21st Dec 202011:53 amRNSNet Asset Value(s)
18th Dec 202012:09 pmRNSNet Asset Value(s)
17th Dec 202012:12 pmRNSNet Asset Value(s)
16th Dec 202010:56 amRNSNet Asset Value(s)
15th Dec 202011:14 amRNSNet Asset Value(s)
14th Dec 20203:46 pmRNSGearing disclosure
14th Dec 202012:20 pmRNSNet Asset Value(s)
14th Dec 202011:10 amRNSPortfolio disclosure
11th Dec 202012:34 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.